Quantifying Pulmonary Inflammation in Cystic Fibrosis with Positron Emission Tomography

Abstract

Imaging with [18F]fluorodeoxyglucose and positron emission tomography can be used to assess inflammatory burden in patients with CF. Elevations in Ki may be able to identify patients with more aggressive disease and may be useful in monitoring changes in inflammatory burden in response to novel treatments.